Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Ustekinumab 130mg/26ml solution for infusion vials |
| BNF code | 0105030B0AAAAAA |
| Virtual Therapeutic Moiety | Ustekinumab |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Caution - AMP level prescribing advised |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 26.000 |
| Unit dose form units | ml |
| Unit dose unit of measure | vial |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Ustekinumab |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 5.000 |
| Strength value numerator unit | mg |
| Strength value denominator | 1.000 |
| Strength value denominator unit | ml |
| Ontology Drug Form & Route | |
| Form & Route | solutioninfusion.intravenous |
| Dose Form | |
| Formulation | Solution for infusion |
| Drug Route | |
| Route | Intravenous |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Pyzchiva 130mg/26ml concentrate for solution for infusion vials (Sandoz Ltd) | |
| Stelara 130mg/26ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) | |
| Wezenla 130mg/26ml concentrate for solution for infusion vials (Amgen Ltd) | |
| Virtual Medicinal Product Packs | |
| Ustekinumab 130mg/26ml solution for infusion vials 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_11.1.0_20241111000001, imported on 12th November 2024 at 03:53:04.